Online Weight Loss Medication in New York: 2026 Guide
New York has nearly 20 million residents and progressive telehealth laws. Here is how New Yorkers can access GLP-1 weight loss medications online.
Medical Disclaimer: This article is for informational purposes only. Weight loss medications require a prescription from a licensed provider.
Whether you are in Manhattan, Buffalo, or anywhere in between, semaglutide and tirzepatide are accessible via telehealth throughout New York state.
New York Telehealth Regulations
- Full prescribing authority: NY-licensed providers can prescribe non-controlled medications via telehealth
- Insurance parity: NY law requires insurers to cover telehealth the same as in-person visits
- Audio-visual: Both video and audio-only visits are permitted
- Informed consent: Providers must obtain verbal or written consent for telehealth
How to Get Started in New York
- Choose a telehealth provider licensed in New York (such as Trimi)
- Complete a medical intake questionnaire
- Meet with a NY-licensed clinician via video
- Receive your prescription if medically appropriate
- Medication ships to your New York address
Insurance Coverage in New York
- Private insurance: Many NY plans cover GLP-1 medications. Empire BCBS, United Healthcare, Aetna, and Cigna each have specific formulary criteria
- NY Medicaid: Some managed care plans cover Wegovy with prior authorization for BMI 30+ or 27+ with comorbidities
- NY State of Health (ACA): Coverage varies by plan tier
- Self-pay: Compounded options through Trimi are the most affordable for uninsured NYers
Cost Comparison
| Option | Monthly Cost | Notes |
|---|---|---|
| Brand Wegovy (cash) | $1,349+ | NYC pharmacies may charge more |
| Brand Zepbound (cash) | $1,059+ | Retail pricing |
| With insurance | $25-$150 | Varies by plan |
| Compounded (Trimi) | $$ | No insurance needed |
New York Cities Served
Trimi serves patients throughout New York via telehealth:
- New York City (all five boroughs), Buffalo, Rochester, Yonkers
- Syracuse, Albany, New Rochelle, Mount Vernon
- Schenectady, Utica, Long Island, Westchester
- All other New York cities and communities
Frequently Asked Questions
Can I get weight loss medication online in New York?
Yes. New York has robust telehealth laws that allow licensed providers to prescribe medications including GLP-1 weight loss medications after a video consultation. No in-person visit is required for initial prescriptions.
Does New York Medicaid cover GLP-1 for weight loss?
New York Medicaid has expanded coverage for some GLP-1 medications. Wegovy may be covered with prior authorization and documented BMI criteria. Coverage varies by managed care plan. Contact your plan directly for specific formulary information.
How much does weight loss medication cost in New York?
New York has among the highest prescription drug costs in the country. Brand-name GLP-1 medications cost $1,000-$1,600+ per month without insurance. Compounded options through telehealth providers like Trimi offer a significantly more affordable alternative.
Can I use my NY insurance for telehealth weight loss?
New York requires insurance parity for telehealth services, meaning your insurer must cover telehealth visits the same as in-person. However, medication coverage depends on your plan's formulary. Many NY plans cover GLP-1 medications with prior authorization.
Get Started in New York Today
Trimi serves patients across New York with affordable GLP-1 treatment. Start your online consultation now.
Get Started TodayMore on State Guides
Online Weight Loss Medication in Pennsylvania
Pennsylvania access guide for weight loss medications.
Online Weight Loss Medication in California
California telehealth options for GLP-1.
Online Weight Loss Medication in Florida
Florida access guide.
GLP-1 Without Insurance 2026
Affordable GLP-1 without insurance.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).